Neoplasia/BPH

	The diagnostic value of mpMRI and PSMA-targeted PET/CT in radiorecurrent prostate cancer: a narrative review. Front Oncol Merani U, Venturi A, Calleris G, Dematteis A, Iorio GC, Marquis A, Sasia A, Marra G, Gontero P, Oderda M. PMID: 42094204 [PubMed]
	Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancer. medRxiv Song Y, Rojo Domingo M, Nguyen L, Conlin CC, Dhillon N, Do S, Dornisch A, Hahn ME, Karunamuni R, Kim J, Lee KL, Liu J, McKay RR, Mell LK, Mundt AJ, Patel R, Qiao EM, Rose B, Rupareliya R, Schaub H, Schwartzman A, Stewart T, Dale AM, Seibert TM. PMID: 42094159 [PubMed]
	Testicular cancer incidence and associations with prior epididymo-orchitis or urinary tract infections: a national cohort study in Sweden, 1964-2018. BMJ Oncol Jansåker F, Li X, Sundquist K. PMID: 42094024 [PubMed]
	RNA methylation in urological cancers: regulatory logic, biological functions, and clinical relevance. Front Immunol Peng J, Xie C, Xie Z, Tang F, Wang Z, Liu M, Yu L, Tang C, Liu Z, Yuan Z, Liao L, Zou X, Liu X, Yi M, Tao H, Wei W, Liu T, Liao Y. PMID: 42093977 [PubMed - indexed for MEDLINE]
	Modifiable risk factors of prostate cancer: Insights from a hospital-based study. Oncoscience Kulshekar M, Patil AB, Nerli RB. PMID: 42093920 [PubMed]
	External beam focal boost radiotherapy to intraprostatic lesions in prostate cancer: a scoping review. Phys Imaging Radiat Oncol Liu Y, Qin S, Ren X, Bai Y, Gao X, Li H, Ma M. PMID: 42093677 [PubMed]
	Early Detection of Biochemical Recurrence in Prostate Cancer Patients with PSA Levels â‰¤0.5 ng/mL; Comparison Study between [Â¹â¸F]PSMA-1007 and [â¶â¸Ga]Ga-PSMA-11 PET/CT. World J Mens Health Cho S, Seo HJ, Bang S, Lee S, Cho KS, Lee S, Yun M. PMID: 42093259 [PubMed - as supplied by publisher]
	Precision Oncology with (177)Lu-PSMA-617 Radionuclide Therapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer. Cancer Biother Radiopharm Zhou F, Zheng Y, Huang L, Tang X, Yang L, Shao S. PMID: 42093168 [PubMed - as supplied by publisher]
	Oligometastatic prostate cancer - bridging the gap between localized and metastatic disease. Nat Rev Urol Giesen A, den Hartog J, Van Goubergen J, Rans K, Baldewijns M, Gevaert T, Goffin K, Everaerts W, Claessens F, De Meerleer G, Joniau S. PMID: 42092023 [PubMed - as supplied by publisher]
	Is Open Partial Nephrectomy Still an Option in the Robotic Era? Curr Urol Rep Michael P, Blachman-Braun R, Loebach L, Fu H, Millan B, Saini J, Gurram S, Linehan WM, Ball M. PMID: 42091753 [PubMed - indexed for MEDLINE]
	Diagnostic Challenge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Case Requiring Prostate Rebiopsy After an Inconclusive Metastatic Lung Biopsy. Intern Med Nakagaki S, Ito T, Sugiura K, Suzuki H, Morishita T, Taki S, Miyazawa A, Hayashi N, Hibino Y. PMID: 42091458 [PubMed - as supplied by publisher]
	Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Nguyen DD, Tadayon Najafabadi B, Lin L, Kwong JCC, Miller E, Zlotta AR, Fleshner NE, Hird AE, Lofters AK, Wallis CJD, Rosella LC, Dahm P, Guyatt G, Kulkarni GS. PMID: 42091407 [PubMed - as supplied by publisher]
	Molecular Pathology of Genitourinary Tumors: Diagnostic, Prognostic, and Therapeutic Implications. Surg Pathol Clin Cimadamore A, Lopez-Beltran A, Montironi R, Cheng L. PMID: 42091277 [PubMed - indexed for MEDLINE]
	Dutasteride treatment and its effect on standardized uptake values in prostate-specific membrane antigen-PET imaging: A pilot study. PLoS One Praetzel L, Burger IA, Rüschoff JH, Rupp NJ, Eberli D, Kranzbühler B. PMID: 42090407 [PubMed - indexed for MEDLINE]
	Face and content validation of laser enucleation of prostate simulation model: an EAU European School of Urology (ESU) Lower Urinary Tract Endoscopy Working Group study. World J Urol Sener TE, de Oliveira TR, Demirkiran ED, Perri D, Pereira S, Caballero JP, Osorio L, Kartalas IG, Goossens M, Schoensee B, Dragos L, Veneziano D, Biyani CS, Somani B, Liatsikos E. PMID: 42090017 [PubMed - indexed for MEDLINE]
	Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis. Acta Oncol Caeyman A, Mammone G, Kinget L, Baldewijns M, De Wever L, Albersen M, Debruyne PR, Demeulenaere O, McTaggart ES, Saraswat S, Berghen C, De Meerleer G, Naulaerts S, Garg AD, Beuselinck B. PMID: 42089693 [PubMed - indexed for MEDLINE]
	Â¹â·â·lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer. Expert Rev Anticancer Ther Sciortino C, Nuzzo A, Stellato M, Claps M, Rametta A, Guadalupi V, Gusmaroli E, Rota S, Mascaro F, Giannatempo P, Zimatore M, Maccauro M, Huber V, Verzoni E, Procopio G. PMID: 42089687 [PubMed - as supplied by publisher]
	Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trial. BJU Int Sharifi SHH, Williams A, Ryan JT, Ajami T, Nativ OF, Han S, Reis IM, Soodana-Prakash N, Khandekar A, Swain S, Kryvenko ON, Stoyanova R, Pollack A, Castillo PR, Nahar B, Ritch CR, Kava B, Gonzalgo ML, Parekh DJ, Punnen S. PMID: 42089595 [PubMed - as supplied by publisher]
	Multi-omics insights into tumor grade progression in clear cell renal cell carcinoma: from molecular mechanisms to precision therapeutics. Front Cell Dev Biol Jena RS, Mishra A. PMID: 42089114 [PubMed]
	Outcomes of pelvic radiotherapy with boost strategies in high nodal-risk prostate cancer: A phase 2 prospective trial. Clin Transl Radiat Oncol Thellenberg Karlsson C, Notstam K, Tavelin B, Lundqvist K, Fransson P, Söderkvist K. PMID: 42088776 [PubMed]

Articles 1 - 20 / 187632

Page 1 of 9382



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy